Cholangitis, Sclerosing Clinical Trial
Official title:
An Efficacy Trial of Low Dose All-trans Retinoic Acid (ATRA) in Patients With Primary Sclerosing Cholangitis
The purpose of this research study is to determine whether a low dose of ATRA will improve laboratory tests of liver and bile duct inflammation in patients with PSC. The investigators will also look for changes to other blood tests which are related to inflammation, scarring, and the immune system.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01456468 -
Combination Therapy With Ursodeoxycholic Acid (UDCA) and All-Trans Retinoic Acid (ATRA) for Treatment of Primary Sclerosing Cholangitis
|
Phase 1 | |
| Completed |
NCT00004842 -
Pilot Study of Budesonide for Patients With Primary Sclerosing Cholangitis
|
Phase 1 | |
| Completed |
NCT00587236 -
Compare Conventional Colonosocpy to Endoscopic AFI, NBI for Dysplasia Detection for Ulcerative Colitis & Cholangitis
|
N/A | |
| Withdrawn |
NCT03678480 -
A Study of HTD1801 in Adolescents With Primary Sclerosing Cholangitis (PSC)
|
Phase 2 | |
| Recruiting |
NCT03146936 -
Swiss Primary Sclerosing Cholangitis Cohort Study
|
||
| Recruiting |
NCT00160940 -
Differential Gene Expression of Liver Tissue and Blood From Individuals With Chronic Viral Hepatitis
|
N/A | |
| Recruiting |
NCT02997878 -
Selected Mesenchymal Stromal Cells to Reduce Inflammation in Patients With PSC and AIH
|
Phase 1/Phase 2 | |
| Recruiting |
NCT04181138 -
Primary Sclerosing Cholangitis in Children
|
||
| Completed |
NCT02967926 -
Digital SpyGlass Confirmed Common Bile Duct Stones Clearance Without Fluoroscopy
|
Phase 3 | |
| Completed |
NCT00004762 -
Phase II Pilot Study of Cladribine (2-Chlorodeoxyadenosine; 2-CdA) for Early Stage Primary Sclerosing Cholangitis
|
Phase 2 |